Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Completed · Phase 2

Conditions studied: Kidney Transplantation

In brief

This is a study that will follow transplant patients from Study A3921030 to monitor for long term safety, tolerability and efficacy for 5 additional years, except in Portugal where the study will follow transplant patients through Month 36 posttransplant. Patients will continue their study medications that were previously assigned.

Key facts

Study ID

NCT00658359

Run by

Pfizer

People needed

178

Starts

2008-08-01

Expected to finish

2015-06-01

Last updated by the study team

2018-02-23

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who successfully completed Study A3921030

You may not qualify if…

• Subjects who are on the waiting list for a second kidney transplant or any non-renal organ transplants

Where it is running

• Cedars-Sinai MedicalCenter — Los Angeles, California, United States
• Ronald Reagan UCLA Medical Center — Los Angeles, California, United States
• UCLA Medical Center — Los Angeles, California, United States
• Stanford School of Medicine — Palo Alto, California, United States
• Stanford University Medical Center — Palo Alto, California, United States
• Balboa Institute of Transplantation — San Diego, California, United States
• California Institute of Renal Research — San Diego, California, United States
• Sharp Memorial Hospital — San Diego, California, United States
• California Pacific Medical Center - Pacific Campus — San Francisco, California, United States
• California Pacific Medical Center — San Francisco, California, United States
• UCSF Medical Center - Long Hospital — San Francisco, California, United States
• USCF Medical Center - Connie Frank Transplant Center — San Francisco, California, United States
• University of Colorado Denver — Aurora, Colorado, United States
• Yale-New Haven Hospital — New Haven, Connecticut, United States
• Yale Physicians Building — New Haven, Connecticut, United States
• University Of Florida — Gainesville, Florida, United States
• Tampa General Hospital — Tampa, Florida, United States
• Northwestern University Feinberg School of Medicine — Chicago, Illinois, United States
• NUCATS's Clinical Research Unit — Chicago, Illinois, United States
• University of Michigan Health System — Ann Arbor, Michigan, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• Hurley Medical Center — Flint, Michigan, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Investigational Drug Services (IDS) / UNC Healthcare — Chapel Hill, North Carolina, United States
• Cedars-Sinai Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.